Key PointsViking Therapeutics has a shot at becoming a leader in the weight-loss market.
Loading story…
Loading story…
Key PointsViking Therapeutics has a shot at becoming a leader in the weight-loss market.
Key PointsViking Therapeutics has a shot at becoming a leader in the weight-loss market.
Same desk, different stories
Key PointsSpaceX could be the blockbuster IPO of 2026.
Key PointsA common window to do Roth conversions is your 60s, before RMDs begin.
Key PointsSpaceX is expected to go public soon, with a valuation of $1.75 trillion.
Key PointsGoogle's recent breakthrough has caused Micron's stock to sell off.
Key PointsThe market for weight loss drugs still has plenty of room to grow.
Key PointsRivian is taking a multi-prong approach to growing its business.